Actual Covid infections in India 17 times higher than reported: BHU study, Health News, ET HealthWorld

New Delhi: The actual COVID-19 infections in India may be around 17 times higher than the official figure, a study led by researchers at Banaras Hindu University (BHU) suggests. According to government data, nearly 4.5 crore people in India have been infected with COVID-19 so far. However, the study published in the International Journal of Infectious Diseases (IJID) estimated that the actual coronavirus cases in the country may be between 58 to 98 crores. The research “has shown that the actual corona infection in India was at least 17 times…

Read More

Omicron’s XBB.1.5 is mild but effective at entering human cells: Experts, Health News, ET HealthWorld

Pune: Omicron‘s XBB.1.5, which has been triggering Covid spikes in parts of the US, is comparable to other XBB subvariants in severity, but is less virulent than the Delta and BA2.75 variants of SARS-CoV-2, a study from Pune has found. Experts from BJ Medical College, the National Institute of Virology and the Indian Institute of Science Education and Research teamed up to analyse seven XBB.1.5 patients from Maharashtra – six from Mumbai and one from Pune – and found that Covid in them was mild. All of them recovered at…

Read More

Covid-19: WHO panel debates COVID’s emergency status, Health News, ET HealthWorld

Geneva: The World Health Organization‘s emergency committee on Covid-19 was meeting Friday to discuss whether the pandemic still merits the highest level of global alert. WHO chief Tedros Adhanom Ghebreyesus suggested the emergency phase of the pandemic is not over, pointing to surging numbers of deaths and warning that the global response to the crisis “remains hobbled”. “As we enter the fourth year of the pandemic, we are certainly in a much better position now than we were a year ago, when the Omicron wave was at its peak, and…

Read More

Covid Drug: New oral antiviral drug likely to get Centre’s approval for treating Covid, Health News, ET HealthWorld

Pune: The Union health ministry is likely to include an oral antiviral drug, nirmatrelvir-ritonavir combination, in the country’s upcoming Covid treatment protocol for patients with mild to moderate disease, who are at high risk of developing severe illness. The combination drug, popularly known by the brand name paxlovid, is currently in high demand in China and a few other nations battling the Covid surge. India’s upcoming Covid treatment protocol is expected to be released within a week. “The combination two-tablet oral drug therapy is likely to be recommended in India…

Read More

‘Not afraid of the virus’: Wuhan turns the page on COVID, three years on, Health News, ET HealthWorld

Wuhan: Residents of China’s Wuhan said Monday they were hopeful for the future and no longer afraid of COVID-19, three years after the city was locked down over what was then a mysterious virus. Since Beijing ordered Wuhan sealed off in a bid to suffocate the outbreak in January 2020, COVID has devastated the planet, killing millions and plunging the global economy into turmoil. But life is now back to normal for many across the globe and after almost three years of grueling lockdowns and mandatory mass testing, Beijing last…

Read More

Pharmacists to become vaccinators, 12.5 lakh to get training from May, Health News, ET HealthWorld

NAGPUR: Worried about who will administer vaccines in the absence of doctors and nurses, particularly in rural areas? Now, pharmaceutical shop owners could come to your help. The Indian Pharmaceutical Association (IPA) has started an ambitious programme to turn phamacists into ‘vaccinators’ by providing training. The IPA has set a target to train all 12.5 lakh registered pharmacists in India to take up the role of vaccinators by 2025, which it feels would save at least 25% lives in a global crisis like Covid. The training would commence from May…

Read More

Vaccine death case: Bombay High Court may hear plea soon, Health News, ET HealthWorld

The Bombay High Court is likely to take up this week a petition filed by a man who has blamed side effects of Covid-19 vaccine for his daughter’s death two years ago and sought a ₹1,000 crore compensation from the vaccine’s manufacturer. “The matter will be heard on January 20,” Shubham Lunawat, the brother of the deceased woman, told ET. The court had in September sought a response to the petition from vaccine manufacturer Serum Institute of India, the government and Bill Gates, whose Bill & Melinda Gates Foundation had…

Read More

SII’s free supply of Covishield to Centre: First lot of 80 lakh doses set for dispatch, Health News, ET HealthWorld

New Delhi: Amid a rise in COVID cases in some countries, Serum Institute of India has started supply of Covishield to the Centre free of cost with the first lot of 80 lakh doses set to be dispatched from Saturday, official sources said. Since the launch of the anti-COVID vaccination drive, SII has so far provided 170 crore doses of Covishield to the government. According to an official source, Prakash Kumar Singh, Director – Government and Regulatory Affairs at Serum Institute of India, had written to Union Health Ministry mentioning…

Read More

Covid: In New Rules, Govt Set To Cap Steroid Dose For Hospitalised Ncov Patients, Health News, ET HealthWorld

Pune: Upcoming central government guidelines on COVID treatment will cap steroid dosage for admitted patients with hypoxia (low oxygen levels or breathlessness), health ministry sources said on Wednesday. The revised guidelines will fix the daily lower dose of methylprednisolone injection at 32mg or 40mg of predniselone or an equivalent daily dose of dexamethasone (6mg), irrespective of a patient’s body weight. The guidelines are being drafted and will be released soon, a ministry official said. Many doctors said they had already cut back on steroids for COVID patients, ever since studies…

Read More

Messenger RNA COVID-19 Vaccine: Researcher claims mRNA COVID-19 vaccines can increase serious adverse events; calls for it to be withdrawn from the market, Health News, ET HealthWorld

New Delhi: Joseph Fraiman, an emergency physician and a clinical scientist from Louisiana, claims that the messenger RNA COVID-19 vaccine can increase serious adverse events in people, including sudden cardiac deaths. In a video that surfaced online, Fraiman, who was a lead author of the peer reviewed research that re-analysed Pfizer & Moderna trials for mRNA COVID-19 vaccine, says, “We found the vaccine increases serious adverse events at a rate of one in 800. At the time of the publication, my co-authors and I did not believe our single study…

Read More